Blog
New
Advancing Rare Disease Research with Tapestry
Advancing Rare Disease Research with Tapestry
Rita Bhui
5 Min Read
Share
Understanding Rare Diseases
Rare diseases, often called orphan diseases, impact millions of people worldwide. Although each condition is rare, collectively, they affect about 300 million people globally. With over 7,000 identified rare diseases, these conditions pose unique challenges in diagnosis, treatment, and research.
A rare disease is defined differently across countries. In the U.S., it's a condition affecting fewer than 200,000 people, while in Europe, it's defined as affecting fewer than 1 in 2,000 individuals. Rare diseases include genetic disorders, rare cancers, autoimmune diseases, infectious tropical diseases, and neurodevelopmental disorders like Rett syndrome and fragile X syndrome.
The Challenges of Diagnosis
Diagnosing rare diseases is often a long and difficult journey. Many patients face years of misdiagnoses or delays due to a lack of awareness and access to specialized tests. It can take five to seven years to receive an accurate diagnosis, during which patients may endure unnecessary treatments and emotional stress.
Genetic testing has transformed how rare diseases, especially neurodevelopmental disorders, are diagnosed. Tests like chromosomal microarray analysis, exome sequencing, and targeted gene panels help identify the genetic causes of conditions. Whole genome sequencing provides a broader analysis, while more specific methods like MLPA and Sanger sequencing confirm particular mutations.
Limited Treatments and High Costs
Only about 5% of rare diseases have approved treatments, leaving most patients reliant on experimental therapies or off-label drug use. Treatments, often referred to as orphan drugs, can be prohibitively expensive. In addition, rare diseases receive limited research funding compared to more common conditions, which slows progress in developing new therapies.
Advances and Hope
Despite these challenges, advances in science and medicine offer hope. Genomic sequencing and precision medicine have made it easier to diagnose and understand rare diseases. Collaborative research networks and patient registries are accelerating the discovery of new treatments.
Patient advocacy organizations play a crucial role in raising awareness and providing support. Efforts like Rare Disease Day highlight the importance of research and encourage collective action to address these conditions.
How Tapestry's Combinatorial Pooling Strategy Can Add Value Efficient and Scalable Genomic Screening
Rare disease diagnosis often requires sequencing large numbers of genes across many individuals. The Tapestry approach pools multiple patient samples in structured combinations, enabling large-scale sequencing with reduced costs and reagent consumption.
Confident Variant Detection
Since every sample goes into multiple pools based on our algorithmic design, our compression strategy ensures that a genuine variant appears across these structured pools multiple times, providing inherent confirmation. This significantly reduces the risk of false positives caused by sequencing errors.
Conclusion
While rare diseases affect a small number of people individually, their combined impact is significant. Through continued innovation, advocacy, and collaboration, we can improve the lives of those affected by these conditions and ensure they receive the care and attention they deserve. Tapestry's pooling strategy further enhances efficiency in rare disease research by enabling cost-effective and high-confidence variant detection, leading the way for better diagnostics and treatments.
Understanding Rare Diseases
Rare diseases, often called orphan diseases, impact millions of people worldwide. Although each condition is rare, collectively, they affect about 300 million people globally. With over 7,000 identified rare diseases, these conditions pose unique challenges in diagnosis, treatment, and research.
A rare disease is defined differently across countries. In the U.S., it's a condition affecting fewer than 200,000 people, while in Europe, it's defined as affecting fewer than 1 in 2,000 individuals. Rare diseases include genetic disorders, rare cancers, autoimmune diseases, infectious tropical diseases, and neurodevelopmental disorders like Rett syndrome and fragile X syndrome.
The Challenges of Diagnosis
Diagnosing rare diseases is often a long and difficult journey. Many patients face years of misdiagnoses or delays due to a lack of awareness and access to specialized tests. It can take five to seven years to receive an accurate diagnosis, during which patients may endure unnecessary treatments and emotional stress.
Genetic testing has transformed how rare diseases, especially neurodevelopmental disorders, are diagnosed. Tests like chromosomal microarray analysis, exome sequencing, and targeted gene panels help identify the genetic causes of conditions. Whole genome sequencing provides a broader analysis, while more specific methods like MLPA and Sanger sequencing confirm particular mutations.
Limited Treatments and High Costs
Only about 5% of rare diseases have approved treatments, leaving most patients reliant on experimental therapies or off-label drug use. Treatments, often referred to as orphan drugs, can be prohibitively expensive. In addition, rare diseases receive limited research funding compared to more common conditions, which slows progress in developing new therapies.
Advances and Hope
Despite these challenges, advances in science and medicine offer hope. Genomic sequencing and precision medicine have made it easier to diagnose and understand rare diseases. Collaborative research networks and patient registries are accelerating the discovery of new treatments.
Patient advocacy organizations play a crucial role in raising awareness and providing support. Efforts like Rare Disease Day highlight the importance of research and encourage collective action to address these conditions.
How Tapestry's Combinatorial Pooling Strategy Can Add Value Efficient and Scalable Genomic Screening
Rare disease diagnosis often requires sequencing large numbers of genes across many individuals. The Tapestry approach pools multiple patient samples in structured combinations, enabling large-scale sequencing with reduced costs and reagent consumption.
Confident Variant Detection
Since every sample goes into multiple pools based on our algorithmic design, our compression strategy ensures that a genuine variant appears across these structured pools multiple times, providing inherent confirmation. This significantly reduces the risk of false positives caused by sequencing errors.
Conclusion
While rare diseases affect a small number of people individually, their combined impact is significant. Through continued innovation, advocacy, and collaboration, we can improve the lives of those affected by these conditions and ensure they receive the care and attention they deserve. Tapestry's pooling strategy further enhances efficiency in rare disease research by enabling cost-effective and high-confidence variant detection, leading the way for better diagnostics and treatments.
Understanding Rare Diseases
Rare diseases, often called orphan diseases, impact millions of people worldwide. Although each condition is rare, collectively, they affect about 300 million people globally. With over 7,000 identified rare diseases, these conditions pose unique challenges in diagnosis, treatment, and research.
A rare disease is defined differently across countries. In the U.S., it's a condition affecting fewer than 200,000 people, while in Europe, it's defined as affecting fewer than 1 in 2,000 individuals. Rare diseases include genetic disorders, rare cancers, autoimmune diseases, infectious tropical diseases, and neurodevelopmental disorders like Rett syndrome and fragile X syndrome.
The Challenges of Diagnosis
Diagnosing rare diseases is often a long and difficult journey. Many patients face years of misdiagnoses or delays due to a lack of awareness and access to specialized tests. It can take five to seven years to receive an accurate diagnosis, during which patients may endure unnecessary treatments and emotional stress.
Genetic testing has transformed how rare diseases, especially neurodevelopmental disorders, are diagnosed. Tests like chromosomal microarray analysis, exome sequencing, and targeted gene panels help identify the genetic causes of conditions. Whole genome sequencing provides a broader analysis, while more specific methods like MLPA and Sanger sequencing confirm particular mutations.
Limited Treatments and High Costs
Only about 5% of rare diseases have approved treatments, leaving most patients reliant on experimental therapies or off-label drug use. Treatments, often referred to as orphan drugs, can be prohibitively expensive. In addition, rare diseases receive limited research funding compared to more common conditions, which slows progress in developing new therapies.
Advances and Hope
Despite these challenges, advances in science and medicine offer hope. Genomic sequencing and precision medicine have made it easier to diagnose and understand rare diseases. Collaborative research networks and patient registries are accelerating the discovery of new treatments.
Patient advocacy organizations play a crucial role in raising awareness and providing support. Efforts like Rare Disease Day highlight the importance of research and encourage collective action to address these conditions.
How Tapestry's Combinatorial Pooling Strategy Can Add Value Efficient and Scalable Genomic Screening
Rare disease diagnosis often requires sequencing large numbers of genes across many individuals. The Tapestry approach pools multiple patient samples in structured combinations, enabling large-scale sequencing with reduced costs and reagent consumption.
Confident Variant Detection
Since every sample goes into multiple pools based on our algorithmic design, our compression strategy ensures that a genuine variant appears across these structured pools multiple times, providing inherent confirmation. This significantly reduces the risk of false positives caused by sequencing errors.
Conclusion
While rare diseases affect a small number of people individually, their combined impact is significant. Through continued innovation, advocacy, and collaboration, we can improve the lives of those affected by these conditions and ensure they receive the care and attention they deserve. Tapestry's pooling strategy further enhances efficiency in rare disease research by enabling cost-effective and high-confidence variant detection, leading the way for better diagnostics and treatments.